2022 NOSCM | Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL

2022 NOSCM | Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL

Overview

NA

Target Audience

NA

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

William G. Wierda, MD, PhD

Date of Release

May 14th, 2025